Delivery Order SPE2DE21D0005-SPE2D625F8N8L

Award Date 5/20/25
Potential Completion Date 5/23/25
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,479.90 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, to provide APLIGRAF, a specialized skin substitute and wound matrix product. The contract has a period of performance through November 25, 2024 and utilizes a Fixed Price with Economic Price Adjustment pricing structure. Organogenesis is a for-profit manufacturer that has been awarded numerous federal contracts to supply a range...
This federal contract award is for a delivery order (SPE2DE21D0005|SPE2D625F52FT) with a ceiling value of $1,239.95, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit medical manufacturer headquartered in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 fixed-price delivery order is for the supply of the APLIGRAF wound care product. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued at up...
This federal contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF, a tissue regeneration product. The $1,239.95 fixed-price with economic price adjustment contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a completion date of September 25, 2024. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25 million single-award...
This federal contract award, with ID SPE2DE21D0005|SPE2D625F83GA, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer and provider of regenerative medical products. The $1,239.95 fixed-price delivery order contract is for the supply of APLIGRAF, a skin substitute product, to support advanced wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several significant federal Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price delivery order is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration for military personnel and veterans. Organogenesis is an established vendor for the Department of Veterans Affairs (VA) and DLA, holding several significant federal...
This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract, valued at $1,239.95, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical and the Department of Veterans Affairs (VA) for the supply of APLIGRAF, a skin substitute product. The contract has not utilized any set-aside designation, indicating Organogenesis competes as a standard commercial vendor. Organogenesis holds several...
This federal contract award is for the delivery of APLIGRAF wound care products to the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense. The $1,239.95 fixed-price delivery order was awarded to Organogenesis Inc., a leading regenerative medicine company that specializes in advanced wound care and surgical products. Organogenesis has been awarded numerous prime federal contracts to provide wound care dressings, surgical implants, and tissue regeneration...
This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of APLIGRAF, a skin substitute product. The contract is a Delivery Order, with a Ceiling Value of $1,239.95, and a Fixed Price with Economic Price Adjustment pricing type. The contract has an Ultimate Completion Date of April 17, 2025. Organogenesis Inc. is a for-profit...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for APLIGRAF, a skin substitute product. The contract has no set-aside designation, indicating Organogenesis competed as a standard commercial vendor. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F8N8L
    Delivery Order

This federal contract award is for the delivery of APLIGRAF, a skin substitute product, to the Department of Defense (DoD) and the Department of Veterans Affairs (VA). The contract, awarded to Organogenesis Inc., a regenerative medicine company, has a ceiling value of $1,239.95 and a completion date of May 23, 2025. It is a Delivery Order contract with a Fixed Price with Economic Price Adjustment pricing type. The contract is not a set-aside.

Organogenesis is a key supplier of advanced wound care and tissue regeneration products to federal healthcare agencies, including the VA and the Defense Logistics Agency (DLA). The company holds several significant federal Indefinite Delivery Vehicles (IDVs) with the VA and DLA, valued at up to $49.5 million, for a range of wound care, surgical implant, and medical supply products. These contract vehicles enable Organogenesis to provide a comprehensive portfolio of regenerative medicine solutions to support medical treatments across military and veteran healthcare programs.

Generated 8/24/25, 12:59 AM